Fig. 7.

ROC curve and Kaplan-Meier curve analyses of the radiomics-clinical nomogram. ROC curve analyses of one-year, three-years, five-years for bRFS of combined radiomics-clinical nomogram in the training group (A), validation group (C), and testing group I. Kaplan-Meier curve analyses of radiomics-clinical nomogram in the training group (B), validation group (D), and testing group (F). ROC, the receiver operating characteristic. bRFS, biochemical recurrence-free survival. PCa, prostate cancer. RP, radical prostatectomy